INMD Stock Analysis: Buy, Sell, or Hold?
INMD - InMode Ltd. Ordinary Shares
$13.79
0.09 (0.66%)
▲
5d:
+0.29%
30d:
+1.7%
90d:
-6.13%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 27, 2026
24d
Get Alerted When INMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: INMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.35
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$10.77
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INMD is currently trading at $13.79, which is considered fair relative to its 30-day fair value range of $13.21 to $14.06. The stock's valuation (Forward PE: 9.0) is in line with its historical norms (8.9). At these levels, the market is pricing in 0.4% annual earnings growth.
Technical Outlook: Technically, INMD is in a downtrend. The price is approaching resistance at $13.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.00 (+23.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INMD is in a downtrend. The price is approaching resistance at $13.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.00 (+23.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$13.21 -
$14.06
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
86.7%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.3% below Wall St target ($17.00)
- BULLISH: Expecting earnings turnaround to 0.4% growth with 6.1% revenue growth
Fair Price Analysis
30-Day Fair Range
$13.21 -
$14.06
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$13.21
Resistance Level
$13.89
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.01
Wall Street Target
$17.00
(+23.3%)
Revenue Growth (YoY)
6.1%
Earnings Growth (YoY)
-63.5%
Profit Margin
25.3%
Valuation Premium vs History
+0.4% premium
PE vs Historical
9.0 vs 8.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.4%
(market-implied from PE analysis)
1-Year Target
$13.85
(+0%)
2-Year Target
$13.90
(+1%)
3-Year Target
$13.96
(+1%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
PE COMPRESSION
$13.79
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 5.9%)
$37.41
(+171%)
Base:
(SPY PE: 9.0, Growth: 5.9%)
$16.38
(+19%)
Bear:
(PE: 7.7, Growth: 5.9%)
$13.93
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 9.46 | Current EPS (TTM): $1.43
Bull Case
$16.00
(+17%)
Analyst growth 7.5%, PE expands to 10.4
Base Case
$14.54
(+6%)
Market implied 7.5%, PE stable at 9.5
Bear Case
$9.20
(-33%)
Severe decline -20.0%, PE contracts to 8.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: April 02, 2026 6:49 PM ET
Data refreshes hourly during market hours. Next update: 7:49 PM
Data refreshes hourly during market hours. Next update: 7:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
